BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2296625)

  • 1. Naloxone-induced analgesia and morphine supersensitivity effects are contingent upon prior exposure to analgesic testing.
    Poulos CX; Knoke DM; Le AD; Cappell H
    Psychopharmacology (Berl); 1990; 100(1):31-5. PubMed ID: 2296625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J; Schulteis G
    Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different opioid systems may participate in post-electro-convulsive shock (ECS) analgesia and catalepsy.
    Urca G; Yitzhaky J; Frenk H
    Brain Res; 1981 Aug; 219(2):385-96. PubMed ID: 6266608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of naloxone-induced analgesia by pretreatment with morphine.
    Cappell H; Poulos CX; Lê AD
    Pharmacol Biochem Behav; 1989 Oct; 34(2):425-7. PubMed ID: 2560204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation and expression of endogenous pain control mechanisms in rats given repeated nociceptive tests under the influence of naloxone.
    Rochford J; Stewart J
    Behav Neurosci; 1987 Feb; 101(1):87-103. PubMed ID: 3030357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to a nonfunctional hot plate as a factor in the assessment of morphine-induced analgesia and analgesic tolerance in rats.
    Bardo MT; Hughes RA
    Pharmacol Biochem Behav; 1979 Apr; 10(4):481-5. PubMed ID: 461477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressants and opiates interactions: pharmacological and biochemical evidences.
    Baraldi M; Poggioli R; Santi M; Vergoni AV; Bertolini A
    Pharmacol Res Commun; 1983 Oct; 15(9):843-57. PubMed ID: 6647527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of adenosine receptor agonists on analgesic effects of morphine.
    Malec D; Michalska E
    Pol J Pharmacol Pharm; 1990; 42(1):1-11. PubMed ID: 2281016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of dihydropyridine-sensitive Ca(2+) channels during naloxone-induced opioid supersensitivity in rats.
    Gullapalli S; Ramarao P
    Eur J Pharmacol; 2002 Sep; 451(3):271-7. PubMed ID: 12242088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of contextual cues on counterirritation in the development process of analgesic tolerance to morphine.
    Nakama-Kitamura M
    Life Sci; 2002 Dec; 72(4-5):531-40. PubMed ID: 12467893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine-induced analgesia does not involve brain opioids.
    Drago F; Caccamo G; Continella G; Scapagnini U
    Eur J Pharmacol; 1984 Jun; 101(3-4):267-9. PubMed ID: 6468501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine-induced potentiation of morphine analgesia in rat tail-flick test: role of opioid-, alpha2-adrenoceptors and ATP-sensitive potassium channels.
    Campos AR; Santos FA; Rao VS
    Biol Pharm Bull; 2006 Jan; 29(1):86-9. PubMed ID: 16394516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate receptor supersensitivity produced by chronic naloxone treatment: dissociation of morphine-induced antinociception and conditioned taste aversion.
    Bardo MT; Miller JS; Risner ME
    Pharmacol Biochem Behav; 1984 Oct; 21(4):591-7. PubMed ID: 6095324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine- and morphine-induced analgesia and catalepsy. I. Tolerance, cross-tolerance, potentiation, residual morphine levels and naloxone action in the rat.
    Winters WD; Hance AJ; Cadd GG; Quam DD; Benthuysen JL
    J Pharmacol Exp Ther; 1988 Jan; 244(1):51-7. PubMed ID: 3336011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone-induced analgesia: effects of the benzodiazepine antagonist Ro 15-1788.
    Cappell H; Knoke DM; Lê AD; Poulos CX
    Pharmacol Biochem Behav; 1989 Sep; 34(1):197-200. PubMed ID: 2516631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Pharmacol Biochem Behav; 2003 Dec; 76(3-4):493-503. PubMed ID: 14643849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance P-induced long-term blockade of spinal adrenergic analgesia: reversal by morphine and naloxone.
    Nance PW; Sawynok J
    J Pharmacol Exp Ther; 1987 Mar; 240(3):972-7. PubMed ID: 2435888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of morphine and naloxone on behaviour in the hot plate test: an ethopharmacological study in the rat.
    Espejo EF; Stinus L; Cador M; Mir D
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):500-10. PubMed ID: 7862866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological actions of eptazocine (l-1,4-dimethyl-10-hydroxy-2,3,4,5,6,7-hexahydro-1,6-methano-1,H-4-benzazonine). 4. Antagonistic action of naloxone on eptazocine analgesia].
    Nabeshima T; Yamada S; Yamaguchi K; Matsuno K; Kameyama T; Sakakibara S; Matsumoto S
    Nihon Yakurigaku Zasshi; 1983 May; 81(5):411-20. PubMed ID: 6629212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.